Shenzhen University
12
0
0
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Growth and Health Efficacy of Novel Infant Formula : A Randomized Trial
Role: collaborator
Boosting Executive Function With Real-class Exercise
Role: lead
Relationships Between Physical Activity and Inhibitory Control Among College Students
Role: lead
Time-Restricted Feeding on Cardiovascular Health Effects
Role: collaborator
Evaluation of Vascular Structure in Elderly Using High-frequency Ultrasound and Construction of a Multimodal Risk Assessment System for Cardiovascular Diseases: a Multicenter Study
Role: collaborator
Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy
Role: collaborator
Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.
Role: collaborator
Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC
Role: collaborator
Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics
Role: collaborator
Early Socioemotional Intervention for Children With Autism Spectrum Disorder in Hong Kong and Mainland China
Role: collaborator
A Modified Lateral Lumbar Interbody Fusion VS. Transforaminal Lumbar Interbody Fusion for Adult Degenerative Scoliosis
Role: collaborator
Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Non-Hodgkin Lymphoma
Role: collaborator
All 12 trials loaded